CRISPR/Cas9 technology flanked exons 1 and 2 with loxP sites and inserted an FRT-flanked neomycin selection cassette after exon 2. The selection cassette was removed via flp-mediated recombination in ES cells expressing flp recombinase. (J:330347, J:330198)